Profile picture of 高珊珊

高珊珊医生

Profile picture of 高珊珊

临床医学学士(英国),皇家内科医学院院士(澳大利亚),哲学硕士(悉尼)

肿瘤内科医生

“我相信我的每一位患者都应该得到个性化且全面的癌症治疗,包括获得临床试验和最先进的循证治疗方法。”

Biography

介绍

高医生拥有超过 20 年的经验,是一位经验丰富的肿瘤内科医生,分别在新加坡伊丽莎白诺维娜、鹰阁和安微尼亚山医院执业。她对肺癌、头颈癌、乳腺癌和胃肠道癌症有亚专科兴趣。

高医生毕业于英国泰恩河畔纽卡斯尔大学,曾在新加坡国立大学医院 (NUH) 工作,之后在皇家阿尔弗雷德王子医院悉尼癌症中心 (现称为 Chris O’brien Life house) 继续她的肿瘤医学专业研究生培训,并在 Michael Boyer 教授、Stephen Clarke 教授和 Alan Coates 教授的指导下,她于 2003 年获得澳大利亚皇家内科医学院 (Royal Australasian College of Physicians, FRACP) 的研究金。

2002年至2003年,她对个性化癌症治疗的转化研究感兴趣,并在Edison Liu教授的带领下开始在新加坡基因组研究所(Genome Institute of Singapore)工作。随后,她获得了悉尼大学的哲学(医学)硕士学位,研究论文题为“优化结直肠癌的辅助治疗”。

高医生于 2005 年回到悉尼,并被任命为悉尼公立教学医院利物浦医院肿瘤内科主任。她还是新南威尔士大学临床试验部主任、临床讲师和悉尼加文研究所访问科学家。

Research

发表文章

  • p53-regulated Transcriptional Program Associated with Genotoxic Stress-Induced Apoptosis. (P S Kho, Z Wang, L Zhuang, ET Liu, Q Yu et al; Journal of Biological Chemistry, Vol.279, Issue 20, 21183-21192, May 14, 2004)

  • Multicenter validation of the Chinese University Prognostic Index (CUPI) for hepatocellular carcinoma (T Leung, F Mo, M Boyer, P Kho, A Chang, J Wong for the Cancer Therapeutics Group, ASCO Proceedings 2003, abstract 1040)

  • A review of demographics and treatment outcomes of patients with stage III Non Small Cell Lung Cancer (NSCLC) in Southwestern Sydney. M Moore, P Kho; Poster for Medical Oncology Group Annual Meeting 2006

  • Demographic and pathological variables in stage 4 colon cancer (CC) patients with a resected primary tumour: analysis of the South Western Sydney Colorectal Tumour Group (SSWCTG) database. Sayed Ali, Patricia Kho, Bin B.Jalaludin, Siu Kin C. Wong; presented at World GI 2009, Barcelona and Medical Oncology Group Annual Meeting 2009 (oral presentation)

  • Wei Chua, Patricia S Kho, Melissa M Moore, Kellie A Chrales and Stephen J Clarke Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer. Critical Reviews in Oncology and Hematology (in press)

  • Is it Prime Time for Personalized Medicine in Oncology? Patricia S Kho, Wei Chua, Melissa M Moore and Stephen J Clarke Personalized Medicine, July 2010, Vol. 7, No. 4, Pages 387-397.

  • Adjuvant chemotherapy for Stage C Rectal cancer. Patricia Kho, Pierre Chapius, Stephen Clarke et al. Colorectal Diseases

“我相信我的每一位患者都应该得到个性化且全面的癌症治疗,包括获得临床试验和最先进的循证治疗方法。”

Languages spoken

  • Mandarin
  • 英语

发表文章

  • p53-regulated Transcriptional Program Associated with Genotoxic Stress-Induced Apoptosis. (P S Kho, Z Wang, L Zhuang, ET Liu, Q Yu et al; Journal of Biological Chemistry, Vol.279, Issue 20, 21183-21192, May 14, 2004)

  • Multicenter validation of the Chinese University Prognostic Index (CUPI) for hepatocellular carcinoma (T Leung, F Mo, M Boyer, P Kho, A Chang, J Wong for the Cancer Therapeutics Group, ASCO Proceedings 2003, abstract 1040)

  • A review of demographics and treatment outcomes of patients with stage III Non Small Cell Lung Cancer (NSCLC) in Southwestern Sydney. M Moore, P Kho; Poster for Medical Oncology Group Annual Meeting 2006

  • Demographic and pathological variables in stage 4 colon cancer (CC) patients with a resected primary tumour: analysis of the South Western Sydney Colorectal Tumour Group (SSWCTG) database. Sayed Ali, Patricia Kho, Bin B.Jalaludin, Siu Kin C. Wong; presented at World GI 2009, Barcelona and Medical Oncology Group Annual Meeting 2009 (oral presentation)

  • Wei Chua, Patricia S Kho, Melissa M Moore, Kellie A Chrales and Stephen J Clarke Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer. Critical Reviews in Oncology and Hematology (in press)

  • Is it Prime Time for Personalized Medicine in Oncology? Patricia S Kho, Wei Chua, Melissa M Moore and Stephen J Clarke Personalized Medicine, July 2010, Vol. 7, No. 4, Pages 387-397.

  • Adjuvant chemotherapy for Stage C Rectal cancer. Patricia Kho, Pierre Chapius, Stephen Clarke et al. Colorectal Diseases

搜索

Make an appointment